Last reviewed · How we verify
NCT04385927
Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children
NA trial testing e-Net for Parents of Neurodiverse Children in Post Traumatic Stress Injury in 66 participants. Completed in 31 December 2021.
31 August 2021
Quick facts
| Lead sponsor | IWK Health Centre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 29 June 2020 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- e-Net for Parents of Neurodiverse Children
Conditions studied
- Post Traumatic Stress Injury — all drugs for Post Traumatic Stress Injury →
- Post Traumatic Stress Disorder — all drugs for Post Traumatic Stress Disorder →
Sponsor
IWK Health Centre — full company profile →
Who can join
18 and older, any sex, with Post Traumatic Stress Injury or Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parents of neurodiverse children are more likely to experience traumatic events related to the care of their child/children. This increases the probability to experience Posttraumatic Stress Injury (PTSI). However, interventions addressing PTSI symptoms in parents are rare. In this research project the study investigators will test the feasibility and efficacy of e-NET, a distance-delivered, exposure-based intervention for PTSI adapted to the needs of parents of neurodiverse children. E-NET is an adapted version of the Narrative Exposure Therapy (NET), an evidence-based intervention approach for individuals with PTSI who have experienced repeated or continuous trauma. The intervention will be conducted via videoconferencing with trained paraprofessionals. During the intervention a narrative of both positive and negative (traumatic) experiences in the parents' life will be created. The intervention contains approx. 12 one-on-one sessions with a trained paraprofessional via videoconferencing. The study design is a waitlist control group design. Approx. 20 participants will receive e-NET directly after the baseline survey and 20 participants will receive e-NET approx. 3 months after the baseline survey. To test the efficacy of the intervention, participants will fill out surveys about PTSI and other mental health symptoms before, directly after, and 2 and 6 months after the intervention. Adverse events and distress will be assessed in every session. As part of the baseline, participants will complete the survey "Surviving and Thriving in Parenting Neurodiverse Children" to determine their eligibility for the intervention. Main eligibility criterion is the presence of PTSI symptoms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Online narrative exposure therapy for parents of children with neurodevelopmental disabilities suffering from posttraumatic stress symptoms - study protocol of a randomized controlled trial.
Kaltenbach E, Chisholm M, Xiong T, Thomson D, et al · · 2021 · cited 3× · PMID 34868484 · DOI 10.1080/20008198.2021.1991650
Verify or expand the search:
- PubMed search for NCT04385927
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other IWK Health Centre trials
Trials by the same sponsor.
- NCT06797076 — App-Based Migraine Treatment: The Health enSuite Study · NA · not yet recruiting
- NCT07112430 — Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants · Phase 1, PHASE2 · not yet recruiting
- NCT07165782 — Brief Videos Delivered by Text Messages as a Public Health Intervention for PTSD in Youth · NA · recruiting
- NCT06968377 — The COVID Dome Trial · NA · not yet recruiting
- NCT07284329 — Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04385927 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IWK Health Centre
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04385927.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing